newsfilter
← Latest News
Business Wire·

AlloVir to Present at the 41st Annual J.P. Morgan Healthcare Conference

AlloVir, Inc. (NASDAQ:ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare